Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000-1.
Poikonen-Saksela P, Lindman H, Sverrisdottir A, Edlund P, Villman K, Tennvall Nittby L, Cold S, Bechmann T, Stenbygaard L, Ejlertsen B, Andersson M, Blomqvist C, Bergh J, Ahlgren J.
Poikonen-Saksela P, et al. Among authors: lindman h.
Acta Oncol. 2020 Jul;59(7):825-832. doi: 10.1080/0284186X.2020.1757149. Epub 2020 Apr 29.
Acta Oncol. 2020.
PMID: 32347139
Clinical Trial.